HHT, an Orphan Disease, is the second most common inherited bleeding disorder in ... There are no drugs approved to treat HHT and Vaderis aims to be the first company to develop a medicine for the ...
Each year, millions of catheters are used worldwide to treat vascular diseases, including heart problems and artery blockages. However, one common challenge during these procedures is the friction ...
It combines the safety and patency of a fistula with the speed to treatment of an AV graft. The aXess vascular access conduit offers an improved dialysis patient experience and avoids the frequent ...
MIPLYFFA was granted Breakthrough Therapy designation, Rare Pediatric Disease designation, Orphan Drug designation ... Celiprolol is an investigational clinical candidate for the treatment of Vascular ...